glp-1 colorectal cancer risk study november 2025 Could drugs reduce progression? Swipe to learn more ππ½ Reference: Orland M. Can GLP-1 receptor agonists mitigate cancer progression? A propensity-matched analysis across seven solid tumors. To be presented at Frontiers | Reassessing cancer risk
Pay in 4 interest-free payments of $6.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 6 - Aug 11


















